NGL Fine-Chem informs about revised investor presentation

28 May 2024 Evaluate

Pursuant to Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, NGL Fine-Chem has informed that it enclosed Revised Investor Presentation for the quarter and year ended March 31, 2024. The earlier Investor Presentation had some errors in financials which are now been rectified.

The above information is a part of company’s filings submitted to BSE.

NGL Fine-Chem Share Price

1291.45 -35.75 (-2.69%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×